We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Abbott Hits Sandoz With New Niaspan Patent Suit

Law360 (February 18, 2011, 1:43 PM EST) -- Abbott Laboratories has launched another patent infringement suit against Sandoz Inc. in an effort to keep a generic version of blockbuster cholesterol drug Niaspan off the market.

Mary B. Graham of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.